- Home
- ORIC vs UDMY Comparison
ORIC vs UDMY Comparison
Compare ORIC & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- UDMY
- Stock Information
- Founded
- ORIC 2014
- UDMY 2009
- Country
- ORIC United States
- UDMY United States
- Employees
- ORIC N/A
- UDMY N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- UDMY Other Consumer Services
- Sector
- ORIC Health Care
- UDMY Real Estate
- Exchange
- ORIC Nasdaq
- UDMY Nasdaq
- Market Cap
- ORIC 974.1M
- UDMY 1.1B
- IPO Year
- ORIC 2020
- UDMY 2021
- Fundamental
- Price
- ORIC $11.07
- UDMY $7.44
- Analyst Decision
- ORIC Strong Buy
- UDMY Buy
- Analyst Count
- ORIC 8
- UDMY 10
- Target Price
- ORIC $16.57
- UDMY $9.89
- AVG Volume (30 Days)
- ORIC 961.7K
- UDMY 1.7M
- Earning Date
- ORIC 11-11-2025
- UDMY 10-28-2025
- Dividend Yield
- ORIC N/A
- UDMY N/A
- EPS Growth
- ORIC N/A
- UDMY N/A
- EPS
- ORIC N/A
- UDMY N/A
- Revenue
- ORIC N/A
- UDMY $795,538,000.00
- Revenue This Year
- ORIC N/A
- UDMY $2.51
- Revenue Next Year
- ORIC N/A
- UDMY $4.18
- P/E Ratio
- ORIC N/A
- UDMY N/A
- Revenue Growth
- ORIC N/A
- UDMY 3.93
- 52 Week Low
- ORIC $3.90
- UDMY $5.68
- 52 Week High
- ORIC $14.67
- UDMY $10.61
- Technical
- Relative Strength Index (RSI)
- ORIC 58.52
- UDMY 59.88
- Support Level
- ORIC $10.37
- UDMY $6.93
- Resistance Level
- ORIC $11.16
- UDMY $7.41
- Average True Range (ATR)
- ORIC 0.54
- UDMY 0.25
- MACD
- ORIC 0.04
- UDMY 0.06
- Stochastic Oscillator
- ORIC 82.14
- UDMY 97.35
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.